| Literature DB >> 31218778 |
Stefan A Lipman1, Arthur E Attema1.
Abstract
Many health economic studies assume expected utility maximisation, with typically a concave utility function to capture risk aversion. Given these assumptions, Rabin's paradox (RP) involves preferences over mixed gambles yielding moderate outcomes, where turning down such gambles imply absurd levels of risk aversion. Although RP is considered a classic critique of expected utility, no paper has as of yet fully tested its preferences within individuals. In an experiment we report a direct test of RP in the health domain, which was previously only considered in the economic literature, showing it may have pervasive implications here too. Our paper supports the shift towards alternative, empirically valid models, such as prospect theory, also in the health domain. These alternative models are able to accommodate Rabin's paradox by allowing reference-dependence and loss aversion.Entities:
Keywords: Rabin's paradox; expected utility; loss aversion; reference dependence; risk aversion
Mesh:
Year: 2019 PMID: 31218778 PMCID: PMC6771755 DOI: 10.1002/hec.3918
Source DB: PubMed Journal: Health Econ ISSN: 1057-9230 Impact factor: 3.046
Scenarios for Rabin paradox (RP) gamble‐pairs for individual and societal outcomes
| Gamble‐pair | Scenario | Outcome |
|---|---|---|
|
| ||
| RP1 | Imagine that it is possible to take a gamble that affects your remaining lifetime (e.g., living until 87). The outcome is added or deducted from your lifetime. | Hours |
| RP2 | Imagine that you are 75 and will live with slight mobility problems (not able to walk more than 3 km). You can gamble to change your lifetime (longer or shorter). | Hours |
| RP3 | Imagine you are 75 and will live until 85 with light back pain (e.g., treatable with mild painkillers). You can gamble to change your life time. | Hours |
|
| ||
| RP4 | Imagine a chronic disease, which leads to considerable losses in quality and length of life. Normally this disease affects about 300,000 people in the Netherlands (e.g., cancer). A risky drug is developed, which may either increase the amount of cases or decrease the amount of cases. | Cases averted/extra cases |
| RP5 | Imagine an outbreak of a fatal disease occurred. The disease will lead to considerable lives lost. You are considering to take a gamble, in which either 11 lives are saved or 10 additional lives are lost. | Casualties saved/extra casualties |
| RP6 | Imagine you have the chance to obtain extra healthy life years for society, be means of an easy to implement, costless, 3 medical procedure. As a reminder: you do not know to whom these life years will be distributed. The procedure also has a chance of resulting in a reduction of healthy life years for society. | Life years |
Note. Each gamble‐pair had the following forms, with numbers referring to different health outcomes depending on the pair: (a) Moderate Stake Gamble : (+11, 0.5, −10) and (b) Calibrated Gamble : (+10.000, 0.5, −100)
RP gamble‐pairs with number of acceptances (acc.) vs. rejections (rej.) for moderate stake gambles (MSG, in columns) and calibrated gambles (in rows), with row and column totals (tot.)
| Individual setting | RP1‐MSG | RP2‐MSG | RP3‐MSG | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Calibrated Gambles | Rej. | Acc. | (Tot.) | Rej. | Acc. | (Tot.) | Rej. | Acc. | (Tot.) | |
| RP1‐RP3
|
| 15 | 3 | (18) | 35 | 8 | (43) | 26 | 4 | (30) |
|
| 94+ | 89 | (183) | 87+ | 71 | (158) | 93+ | 78 | (181) | |
|
| (109) | (92) | (123) | (79) | (119) | (82) | ||||
Note. aRP preferences are signified by +.
The total proportion is significantly larger than 50%, by a pairwise ‐test with p< 0.05.
Frequency (N) and proportion (%) of RP preferences counts (C) within‐subjects
|
| Societal | |||||
|---|---|---|---|---|---|---|
| C = 0 | C = 1 | C = 2 | C = 3 | Total individual | ||
| Individual | C = 0 | 19 (9%) | 21 (10%) | 22 (11%) | 22 (11%) | 84 (42%) |
| C = 1 | 2 (1%) | 6 (3%) | 9 (4%) | 8 (4%) | 25 (12%) | |
| C = 2 | 4 (2%) | 5 (2%) | 9 (4%) | 9 (4%) | 27 (13%) | |
| C = 3 | 8 (4%) | 12 (6%) | 18 (9%) | 27 (13%) | 65 (32%) | |
| Total societal | 33 (16%) | 44 (22%) | 58 (29%) | 66 (33%) | ||